• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重持续性新生儿肺动脉高压患儿长期神经发育随访中轻度神经缺陷的高发:一项队列研究。

High prevalence of minor neurologic deficits in a long-term neurodevelopmental follow-up of children with severe persistent pulmonary hypertension of the newborn: a cohort study.

机构信息

Neonatology Division, AO S. Chiara, Trento, Italy.

出版信息

Ital J Pediatr. 2010 Jun 13;36:45. doi: 10.1186/1824-7288-36-45.

DOI:10.1186/1824-7288-36-45
PMID:20540801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2901230/
Abstract

BACKGROUND

Persistent pulmonary hypertension of the newborn (PPHN) is a severe condition that determines a profound brain hypoxia. Inhaled nitric oxide was approved for the treatment of PPHN since the end of the 1990s. The debate upon the long term outcome of these children is still open. Our aim was to investigate the incidence of minor long-term neurodevelopmental problems in a cohort of children affected by severe PPHN.

METHODS

All neonates with severe PPHN treated with inhaled nitric oxide in our facility between 01.01.02 and 31.12.07 were seen in a follow up visit and evaluated with a neurodevelopmental scale, according to their age at the time of observation.

RESULTS

in the study period 31 children were diagnosed with severe PPHN. 29 survived. 27 accepted to come for follow-up. Mean age: 41 months (range 12 - 70 months).26% of the evaluated children had some behavioural problems, while 22% had some language disturbances.

CONCLUSIONS

This is the first neurodevelopmental follow-up of neonates with PPHN in which children older than 36 months have been evaluated.There is an unexpected high incidence of minor neurological deficits, mainly regarding the fields of language and behaviour. These deficits seem to be related to the severity of illness rather than to the treatment. Language and behaviour are considered "higher functions" in humans and their integrity can be better defined in older children.

摘要

背景

新生儿持续性肺动脉高压(PPHN)是一种严重的疾病,会导致严重的脑缺氧。自 20 世纪 90 年代末以来,吸入一氧化氮已被批准用于治疗 PPHN。关于这些儿童的长期预后的争论仍在继续。我们的目的是调查一组患有严重 PPHN 的儿童中轻度长期神经发育问题的发生率。

方法

在 2002 年 1 月 1 日至 2007 年 12 月 31 日期间,在我们医院接受吸入一氧化氮治疗的所有患有严重 PPHN 的新生儿均在随访中接受检查,并根据其观察时的年龄使用神经发育量表进行评估。

结果

在研究期间,31 名儿童被诊断为严重 PPHN。29 名存活。27 名同意进行随访。平均年龄:41 个月(范围 12-70 个月)。26%的评估儿童存在一些行为问题,而 22%存在一些语言障碍。

结论

这是对患有 PPHN 的新生儿进行的首次神经发育随访,其中对年龄大于 36 个月的儿童进行了评估。存在意外的轻度神经发育缺陷高发生率,主要涉及语言和行为领域。这些缺陷似乎与疾病的严重程度有关,而与治疗无关。语言和行为被认为是人类的“高级功能”,其完整性可以在年龄较大的儿童中更好地定义。

相似文献

1
High prevalence of minor neurologic deficits in a long-term neurodevelopmental follow-up of children with severe persistent pulmonary hypertension of the newborn: a cohort study.严重持续性新生儿肺动脉高压患儿长期神经发育随访中轻度神经缺陷的高发:一项队列研究。
Ital J Pediatr. 2010 Jun 13;36:45. doi: 10.1186/1824-7288-36-45.
2
Persistent pulmonary hypertension of the newborn in extremely preterm infants: a Japanese cohort study.新生儿持续肺动脉高压与极早产儿:一项日本队列研究。
Arch Dis Child Fetal Neonatal Ed. 2018 Nov;103(6):F554-F561. doi: 10.1136/archdischild-2017-313778. Epub 2018 Jan 3.
3
Clinical Characteristics and Risk Factors for Developing Pulmonary Hypertension in Children with Down Syndrome.唐氏综合征儿童发生肺动脉高压的临床特征及危险因素。
J Pediatr. 2018 Nov;202:212-219.e2. doi: 10.1016/j.jpeds.2018.06.031. Epub 2018 Jul 17.
4
Persistent pulmonary hypertension in neonates with perinatal asphyxia and therapeutic hypothermia: a frequent and perilous combination.围产期窒息并低温治疗的新生儿持续性肺动脉高压:一种常见且危险的组合。
J Matern Fetal Neonatal Med. 2022 Dec;35(25):4969-4975. doi: 10.1080/14767058.2021.1873941. Epub 2021 Feb 21.
5
Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide.接受一氧化氮治疗的足月儿持续性肺动脉高压的神经发育和医学转归
J Pediatr. 2002 Mar;140(3):306-10. doi: 10.1067/mpd.2002.122730.
6
Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension.
J Pediatr. 1997 Jul;131(1 Pt 1):70-5. doi: 10.1016/s0022-3476(97)70126-4.
7
Risk of persistent pulmonary hypertension of the neonate in twin-to-twin transfusion syndrome.双胎输血综合征中新生儿持续性肺动脉高压的风险。
Neonatology. 2007;92(2):134-8. doi: 10.1159/000101433. Epub 2007 Mar 29.
8
Variable oxygenation response to inhaled nitric oxide in severe persistent pulmonary hypertension of the newborn.
Acta Paediatr. 1995 Nov;84(11):1305-8. doi: 10.1111/j.1651-2227.1995.tb13554.x.
9
Is inhaled nitric oxide a miraculous molecule? The analysis of nitric oxide use in newborns with persistent pulmonary hypertension of the newborn.吸入一氧化氮是一种神奇的分子吗?对新生儿持续肺动脉高压使用一氧化氮的分析。
Bratisl Lek Listy. 2022;123(3):153-159. doi: 10.4149/BLL_2022_026.
10
Infant lung function after inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn.
Pediatr Pulmonol. 1999 Jul;28(1):24-30. doi: 10.1002/(sici)1099-0496(199907)28:1<24::aid-ppul5>3.0.co;2-m.

引用本文的文献

1
Global, regional and national trends in the burden of persistent pulmonary hypertension of the newborn and essentials of its management from 1993 to 2023: a scoping review.1993年至2023年全球、区域和国家新生儿持续性肺动脉高压负担趋势及其管理要点:一项范围综述
Front Pediatr. 2025 Jun 4;13:1502385. doi: 10.3389/fped.2025.1502385. eCollection 2025.
2
Neurodevelopmental outcome in children between one and five years after persistent pulmonary hypertension of term and near-term newborns.足月儿和近足月儿持续性肺动脉高压患儿1至5岁时的神经发育结局。
Front Pediatr. 2024 Oct 23;12:1450916. doi: 10.3389/fped.2024.1450916. eCollection 2024.
3
Association of Right Ventricular Dysfunction with Risk of Neurodevelopmental Impairment in Infants with Pulmonary Hypertension.肺动脉高压婴儿右心室功能障碍与神经发育障碍风险的关联
Children (Basel). 2024 Sep 13;11(9):1121. doi: 10.3390/children11091121.
4
Decreased OLA1 (Obg-Like ATPase-1) Expression Drives Ubiquitin-Proteasome Pathways to Downregulate Mitochondrial SOD2 (Superoxide Dismutase) in Persistent Pulmonary Hypertension of the Newborn.下调 OLA1(Obg-Like ATPase-1)表达通过泛素-蛋白酶体途径下调新生持续性肺动脉高压中线粒体 SOD2(超氧化物歧化酶)。
Hypertension. 2019 Oct;74(4):957-966. doi: 10.1161/HYPERTENSIONAHA.119.13430. Epub 2019 Sep 3.
5
Impaired cerebral angiogenesis in the fetal lamb model of persistent pulmonary hypertension.持续性肺动脉高压胎羊模型中脑内血管生成受损。
Int J Dev Neurosci. 2014 Nov;38:113-8. doi: 10.1016/j.ijdevneu.2014.08.003. Epub 2014 Aug 27.
6
Perinatal factors associated with poor neurocognitive outcome in early school age congenital diaphragmatic hernia survivors.围产期因素与先天性膈疝幸存者早期学龄期神经认知结局不良相关。
J Pediatr Surg. 2013 Apr;48(4):730-7. doi: 10.1016/j.jpedsurg.2012.09.026.
7
Antenatal betamethasone improves postnatal transition in late preterm lambs with persistent pulmonary hypertension of the newborn.产前倍他米松可改善患有新生儿持续性肺动脉高压的晚期早产儿的产后过渡期。
Pediatr Res. 2013 May;73(5):621-9. doi: 10.1038/pr.2013.20. Epub 2013 Jan 31.
8
Neurodevelopmental outcome of newborns with persistent pulmonary hypertension.持续性肺动脉高压新生儿的神经发育结局
Malays J Med Sci. 2011 Oct;18(4):58-62.

本文引用的文献

1
[Persistent pulmonary hypertension of the newborn. Review of therapeutic approaches].
Arch Pediatr. 2008 Jun;15(5):695-7. doi: 10.1016/S0929-693X(08)71879-7.
2
Airway function in infants treated with inhaled nitric oxide for persistent pulmonary hypertension.吸入一氧化氮治疗持续性肺动脉高压的婴儿的气道功能
Pediatr Pulmonol. 2008 Mar;43(3):224-35. doi: 10.1002/ppul.20733.
3
Inhaled nitric oxide therapy decreases the risk of cerebral palsy in preterm infants with persistent pulmonary hypertension of the newborn.吸入一氧化氮疗法可降低患有新生儿持续性肺动脉高压的早产儿患脑瘫的风险。
Pediatrics. 2007 Jun;119(6):1159-64. doi: 10.1542/peds.2006-2269.
4
Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up.足月和近足月低氧性呼吸衰竭新生儿的早期吸入一氧化氮治疗:神经发育随访
J Pediatr. 2007 Mar;150(3):235-40, 240.e1. doi: 10.1016/j.jpeds.2006.11.065.
5
Nitric oxide for respiratory failure in infants born at or near term.一氧化氮用于足月或近足月出生婴儿的呼吸衰竭。
Cochrane Database Syst Rev. 2006 Oct 18(4):CD000399. doi: 10.1002/14651858.CD000399.pub2.
6
Pulmonary hypertension in children: the twenty-first century.
Pediatr Clin North Am. 2006 Oct;53(5):961-87, x. doi: 10.1016/j.pcl.2006.08.001.
7
Developmental outcome in newborn infants treated for acute respiratory failure with extracorporeal membrane oxygenation: present experience.接受体外膜肺氧合治疗急性呼吸衰竭的新生儿的发育结局:当前经验
Arch Dis Child Fetal Neonatal Ed. 2006 Jan;91(1):F21-5. doi: 10.1136/adc.2004.066290. Epub 2005 Sep 13.
8
Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide.吸入一氧化氮治疗的早产儿的神经发育结局
N Engl J Med. 2005 Jul 7;353(1):23-32. doi: 10.1056/NEJMoa043514.
9
[Administration of inhaled nitric oxide in newborns].
Minerva Anestesiol. 2004 Apr;70(4):245-50.
10
Factors affecting the response to inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn infants.影响新生儿持续性肺动脉高压对吸入一氧化氮治疗反应的因素。
Yonsei Med J. 2004 Feb 29;45(1):49-55. doi: 10.3349/ymj.2004.45.1.49.